Skip to content

The Role of Endogenous GLP-1 (Glycolipoprotein) in Regulating Glucose Stimulated Brain Activity

The Role of Endogenous GLP-1 in Regulating Glucose Stimulated Brain Activity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01918566
Enrollment
12
Registered
2013-08-07
Start date
2012-03-31
Completion date
2013-03-31
Last updated
2013-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exploratory Behavior

Brief summary

Our objective is to investigate neuro-anatomical correlates of the regulation of energy intake by means of functional MRI. Administration of glucose with and without lactisole and exendin as well as fructose is followed by functional brain MRI, and findings are correlated with serum GLP-1 levels as an endogenous satiety signal in humans.

Interventions

DIETARY_SUPPLEMENTtap water
DIETARY_SUPPLEMENTSingle intragastric instillation of 75g Glucose in 300ml tap water via nasogastric tube
DIETARY_SUPPLEMENTSingle intragastric instillation of 75g Glucose in 300ml tap water with 450ppm lactisole
DIETARY_SUPPLEMENT25g Fructose in 300ml tap water
DIETARY_SUPPLEMENT75g glucose in 300ml tap water with 600pmol/kg/min exendin 9-39
DIETARY_SUPPLEMENT300ml tap water with 450ppm lactisole

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* right-handed healthy males, no drugs, non-smoking

Exclusion criteria

* drug abuse, smoker, left-handed, claustrophobia

Design outcomes

Primary

MeasureTime frameDescription
Functional magnetic resonance imaging (fMRI) in healthy volunteers while they performed a working memory task: changes in cerebral blood flow and blood hormones from baseline to treatmentchanges from baseline to one hour after treatmentWhole brain analysis with a cluster-level threshold was followed by an a priori defined region of interest analysis of the dorsolateral prefrontal cortex including a cluster-level threshold and family-wise error adjustment for multiple comparisons.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026